Resumen
Phytochemicals are the basis for many anticancer drugs currently in clinical use, as well as a potential source of future cancer treatments. Some phytochemicals have been found to modify the expression of checkpoint inhibitors of the immune response, as well as kill cancer cells. Cancer cells, in turn, may evade detection by the immune system by expressing molecules such as programmed death ligand 1 (PD-L1) that interacts with programmed cell death 1 (PD-1) on T cells to inhibit T cell activation and effector function. Phytochemicals have direct effects on cancer cells and/or T cells that may impact PD-L1/PD1 interactions, although this may vary depending on the phytochemical in question. Flow cytometric analysis of cancer cells stained with anti-PD-L1 antibodies following treatment with a given phytochemical enables the detection of any alteration in PD-L1 expression. The effect of the phytochemical on T cell function can be assessed using proliferation assays (e.g., tritiated thymidine incorporation, flow cytometric analysis of Oregon Green 488-stained cells) and enzyme-linked immunosorbent assay of interleukin-2 content in culture supernatants. Additional study is needed to better understand the impact of phytochemicals on cancer immunotherapy.
Idioma original | English |
---|---|
Título de la publicación alojada | Methods in Molecular Biology |
Editorial | Humana Press Inc. |
Páginas | 161-173 |
Número de páginas | 13 |
DOI | |
Estado | Published - 2020 |
Serie de la publicación
Nombre | Methods in Molecular Biology |
---|---|
Volumen | 2111 |
ISSN (versión impresa) | 1064-3745 |
ISSN (versión digital) | 1940-6029 |
Nota bibliográfica
Publisher Copyright:© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
ASJC Scopus Subject Areas
- Molecular Biology
- Genetics
PubMed: MeSH publication types
- Journal Article